ScienceAlert on MSN21 小时
Your Cerebrospinal Fluid May Hold a Blueprint For Treating Alzheimer's
Your brain and spinal cord are suspended in about 125 mL of cerebrospinal fluid (CSF) that not only protects your precious ...
Newsweek on MSN14 天
Alzheimer's: Scientists Analyze Body Fluid to Find New Drugs for Disease
Alzheimer's disease—the most common form of dementia—is a progressive neurological disorder that causes brain cells to ...
ALS News Today7 小时
Phase 1 trial now testing 2 new QRL-201 doses in ALS patients
The Phase 1 trial ANQUR, now testing two new doses of the ALS therapy QRL-201, is enrolling patients at 12 sites in Canada and across Europe.
technologynetworks17 天
Cerebrospinal Fluid Study Unveils Potential Alzheimer’s Drug Targets
Using cerebrospinal fluid, researchers have identified proteins and genes linked to Alzheimer's progression that could form ...
Armed robbery in Revesby18 天
Alzheimer's Drug Targets Found in Spinal Fluid
A multitude of genes have been linked to the development of Alzheimer's disease. Specifically how those genes might influence ...
Neuroscience News16 天
Alzheimer’s Linked to Key Proteins via Cerebrospinal Fluid Analysis
Using cerebrospinal fluid from living patients, researchers have identified specific proteins and genetic pathways involved ...
GEN1 小时
Novartis, PTC Ink Up-to-$2.9B Huntington’s Disease Collaboration
Novartis will partner with PTC Therapeutics to develop PTC’s PTC518 Huntington's disease program and an unspecified number of related molecules, through an up-to-$2.9 billion exclusive global license ...